Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  6. System Of Radiation Protection Overview‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Information for healthcare providers (old)‏‎ (24 revisions)
  10. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  11. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. ICRP publications‏‎ (14 revisions)
  20. System of radiation protection module 2‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Absorbed dose‏‎ (9 revisions)
  25. Objectives of Radiological Protection‏‎ (9 revisions)
  26. Air-kerma rate constant‏‎ (9 revisions)
  27. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  28. Prudence‏‎ (8 revisions)
  29. Effects of Exposure‏‎ (8 revisions)
  30. Organ/tissue absorbed dose‏‎ (8 revisions)
  31. Beneficence‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Linear energy transfer‏‎ (6 revisions)
  34. Accelerated fractionation‏‎ (6 revisions)
  35. Investigation level‏‎ (6 revisions)
  36. ICRPædia Guides‏‎ (6 revisions)
  37. Exposure Categories and Situations‏‎ (6 revisions)
  38. Justice‏‎ (6 revisions)
  39. Alimentary tract‏‎ (6 revisions)
  40. Kerma‏‎ (5 revisions)
  41. Protection quantities‏‎ (5 revisions)
  42. Types of materials‏‎ (5 revisions)
  43. Absorbed fraction‏‎ (5 revisions)
  44. Radiation weighting factor‏‎ (5 revisions)
  45. Sources of Radiation Exposure‏‎ (5 revisions)
  46. Quality factor‏‎ (5 revisions)
  47. Air-kerma, entrance surface‏‎ (5 revisions)
  48. Principle of optimisation‏‎ (5 revisions)
  49. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  50. Dose coefficient‏‎ (5 revisions)
  51. Justification‏‎ (5 revisions)
  52. Computed tomography dose index‏‎ (4 revisions)
  53. Direct bioassay‏‎ (4 revisions - redirect page)
  54. Bioassay‏‎ (4 revisions)
  55. Calculating Radon Doses‏‎ (4 revisions)
  56. Alpha decay‏‎ (4 revisions)
  57. Kp index‏‎ (4 revisions)
  58. Effective charge number‏‎ (4 revisions)
  59. Protective action‏‎ (4 revisions)
  60. Reference Animal and Plant‏‎ (4 revisions)
  61. Source-related assessment‏‎ (4 revisions)
  62. Risk‏‎ (4 revisions)
  63. Senescence‏‎ (4 revisions)
  64. Effective half-life‏‎ (4 revisions)
  65. Averted dose‏‎ (4 revisions)
  66. Reference bioassay function‏‎ (4 revisions)
  67. Optimisation‏‎ (4 revisions)
  68. Forbiddenness‏‎ (4 revisions)
  69. Aerodynamic diameter‏‎ (4 revisions)
  70. ICRP‏‎ (4 revisions)
  71. Sievert‏‎ (4 revisions)
  72. Diagnostic reference level‏‎ (4 revisions)
  73. S coefficient (radiation weighted)‏‎ (4 revisions)
  74. Non-maleficence‏‎ (4 revisions)
  75. Air-kerma, product‏‎ (4 revisions)
  76. Fractionation sensitivity‏‎ (4 revisions)
  77. Mass median diameter‏‎ (4 revisions)
  78. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  79. Math‏‎ (4 revisions)
  80. Programmed cell death‏‎ (4 revisions)
  81. High linear energy transfer radiation‏‎ (4 revisions)
  82. Target region‏‎ (3 revisions)
  83. Growth fraction‏‎ (3 revisions)
  84. Excretion rate (instantaneous)‏‎ (3 revisions)
  85. Extrathoracic airways‏‎ (3 revisions)
  86. Galactic cosmic radiation‏‎ (3 revisions)
  87. Growth hormone (somatotropin)‏‎ (3 revisions)
  88. ICRP Publication 103‏‎ (3 revisions)
  89. DNA damage signalling‏‎ (3 revisions)
  90. Potential exposure‏‎ (3 revisions)
  91. Fairness‏‎ (3 revisions)
  92. Absorption‏‎ (3 revisions)
  93. Gamma ray‏‎ (3 revisions)
  94. Cardiomyopathy‏‎ (3 revisions)
  95. Rigidity threshold‏‎ (3 revisions)
  96. Low Earth orbit‏‎ (3 revisions)
  97. Dose equivalent‏‎ (3 revisions)
  98. X ray‏‎ (3 revisions)
  99. Field-size effect (Volume effect)‏‎ (3 revisions)
  100. Gastrointestinal syndrome‏‎ (3 revisions)
  101. Biomedical research volunteer‏‎ (3 revisions)
  102. Dose limit‏‎ (3 revisions)
  103. Unsealed source‏‎ (3 revisions)
  104. Xerostomia‏‎ (3 revisions)
  105. Flexible tissues‏‎ (3 revisions)
  106. Guide to the System of Radiological Protection‏‎ (3 revisions)
  107. Autonomy‏‎ (3 revisions)
  108. Constancy test‏‎ (3 revisions)
  109. Interphase death‏‎ (3 revisions)
  110. Test‏‎ (3 revisions)
  111. Dose‏‎ (3 revisions)
  112. Dose limits‏‎ (3 revisions)
  113. Fluence‏‎ (3 revisions)
  114. Public exposure‏‎ (3 revisions)
  115. DS02‏‎ (3 revisions)
  116. Uptake‏‎ (3 revisions)
  117. Fluoroscopically guided interventions‏‎ (3 revisions)
  118. Annual dose‏‎ (3 revisions)
  119. Cell death‏‎ (3 revisions)
  120. Contamination‏‎ (3 revisions)
  121. Dose of record (E)‏‎ (3 revisions)
  122. Utilitarian ethics‏‎ (3 revisions)
  123. Operational quantity‏‎ (3 revisions)
  124. Accountability‏‎ (3 revisions)
  125. Half-life, physical‏‎ (3 revisions)
  126. Value judgement‏‎ (3 revisions)
  127. Exponential survival curve‏‎ (3 revisions)
  128. Annual limit on intake‏‎ (3 revisions)
  129. Dose per content function‏‎ (3 revisions)
  130. Valvular heart disease‏‎ (3 revisions)
  131. Equity‏‎ (3 revisions)
  132. Personal dose equivalent‏‎ (3 revisions)
  133. Principle of justification‏‎ (3 revisions)
  134. Graded approach‏‎ (3 revisions)
  135. Radiofrequency ablation‏‎ (3 revisions)
  136. Iso-effect plots‏‎ (3 revisions)
  137. Lifetime risk estimates‏‎ (3 revisions)
  138. Virtue ethics‏‎ (3 revisions)
  139. Fractionation‏‎ (3 revisions)
  140. Isomers‏‎ (3 revisions)
  141. Voxel phantom‏‎ (3 revisions)
  142. Active (red) bone marrow‏‎ (3 revisions)
  143. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  144. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  145. Coster-Kronig transition‏‎ (3 revisions)
  146. Organ dose equivalent‏‎ (3 revisions)
  147. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  148. Emergency preparedness‏‎ (3 revisions)
  149. Gray‏‎ (3 revisions)
  150. Spread-out Bragg peak‏‎ (3 revisions)
  151. Emergency procedures‏‎ (3 revisions)
  152. Absolute risk‏‎ (3 revisions)
  153. Auger transition‏‎ (3 revisions)
  154. Recovery‏‎ (3 revisions)
  155. Bystander effect‏‎ (3 revisions)
  156. Complex tissues‏‎ (3 revisions)
  157. Derived air concentration‏‎ (3 revisions)
  158. Dignity‏‎ (3 revisions)
  159. Wisdom‏‎ (3 revisions)
  160. Employer‏‎ (3 revisions)
  161. Activity median thermodynamic diameter‏‎ (3 revisions)
  162. Reversibility‏‎ (2 revisions)
  163. Clonogenic cells‏‎ (2 revisions)
  164. In vivo radiobioassay‏‎ (2 revisions)
  165. Solar particle event‏‎ (2 revisions)
  166. Curie‏‎ (2 revisions)
  167. Effect Dose 50‏‎ (2 revisions)
  168. Worker‏‎ (2 revisions)
  169. Nuclear track detectors‏‎ (2 revisions)
  170. Endogeneous excretion‏‎ (2 revisions)
  171. Exposure to Radon at Home‏‎ (2 revisions)
  172. GATA binding protein 2‏‎ (2 revisions)
  173. Radiation safety officer‏‎ (2 revisions)
  174. Radioresponsiveness‏‎ (2 revisions)
  175. Hormones‏‎ (2 revisions)
  176. Authorization‏‎ (2 revisions)
  177. Recovery responder‏‎ (2 revisions)
  178. Cardiac arrhythmias‏‎ (2 revisions)
  179. Right to know‏‎ (2 revisions)
  180. Clonogenic survival‏‎ (2 revisions)
  181. Incidence‏‎ (2 revisions)
  182. Solar wind‏‎ (2 revisions)
  183. Cytokines‏‎ (2 revisions)
  184. Target tissue‏‎ (2 revisions)
  185. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  186. Working level‏‎ (2 revisions)
  187. OLINDA/EXM‏‎ (2 revisions)
  188. Particle radiance‏‎ (2 revisions)
  189. Protection strategy‏‎ (2 revisions)
  190. Acute radiation syndrome‏‎ (2 revisions)
  191. Radiation source‏‎ (2 revisions)
  192. Radiosensitiser‏‎ (2 revisions)
  193. Hounsfield unit‏‎ (2 revisions)
  194. Authorized limit‏‎ (2 revisions)
  195. Rehabilitation of living conditions‏‎ (2 revisions)
  196. ICRP Publication 118‏‎ (2 revisions)
  197. Cardiac valve diseases‏‎ (2 revisions)
  198. Rigidity‏‎ (2 revisions)
  199. Security‏‎ (2 revisions)
  200. Incident‏‎ (2 revisions)
  201. Intermediate level waste‏‎ (2 revisions)
  202. Stenosis‏‎ (2 revisions)
  203. Local DRL‏‎ (2 revisions)
  204. Disposal‏‎ (2 revisions)
  205. Tolerability‏‎ (2 revisions)
  206. Medical exposure‏‎ (2 revisions)
  207. Dose criteria‏‎ (2 revisions)
  208. Naturally occurring radioactive material‏‎ (2 revisions)
  209. Working level month‏‎ (2 revisions)
  210. Environmental exposure‏‎ (2 revisions)
  211. Exempt waste‏‎ (2 revisions)
  212. Adaptive response‏‎ (2 revisions)
  213. Alveolar-interstitial region‏‎ (2 revisions)
  214. Radiosensitivity, cellular‏‎ (2 revisions)
  215. Autoimmune disease‏‎ (2 revisions)
  216. Co-expertise‏‎ (2 revisions)
  217. Inclusiveness‏‎ (2 revisions)
  218. Connective tissue‏‎ (2 revisions)
  219. Source-related‏‎ (2 revisions)
  220. Internal conversion electron‏‎ (2 revisions)
  221. DRL process‏‎ (2 revisions)
  222. LD 50/30‏‎ (2 revisions)
  223. Telangiectasia‏‎ (2 revisions)
  224. Member of the public‏‎ (2 revisions)
  225. Unattached fraction‏‎ (2 revisions)
  226. Necrosis‏‎ (2 revisions)
  227. Environmental radiation protection‏‎ (2 revisions)
  228. Patient entrance reference point‏‎ (2 revisions)
  229. Exemption level‏‎ (2 revisions)
  230. Potential recoverability correction factor‏‎ (2 revisions)
  231. Protective action guide‏‎ (2 revisions)
  232. Radiation worker‏‎ (2 revisions)
  233. Cardioverter-defibrillator‏‎ (2 revisions)
  234. Self-help protection‏‎ (2 revisions)
  235. Individual-related‏‎ (2 revisions)
  236. Consequential late effects‏‎ (2 revisions)
  237. Storage‏‎ (2 revisions)
  238. Track structure‏‎ (2 revisions)
  239. Mendelian diseases‏‎ (2 revisions)
  240. Neurological syndrome‏‎ (2 revisions)
  241. Effective dose equivalent‏‎ (2 revisions)
  242. Occupational exposure‏‎ (2 revisions)
  243. Peak skin dose‏‎ (2 revisions)
  244. Existing exposure situation‏‎ (2 revisions)
  245. Gastroschisis‏‎ (2 revisions)
  246. Radioactive dispersion device‏‎ (2 revisions)
  247. Angiogenesis‏‎ (2 revisions)
  248. Radon: Units of Measure‏‎ (2 revisions)
  249. Hyperbaric oxygen‏‎ (2 revisions)
  250. Reference air kerma‏‎ (2 revisions)
  251. Bioturbation‏‎ (2 revisions)
  252. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  253. Cohort study‏‎ (2 revisions)
  254. Individual decontamination‏‎ (2 revisions)
  255. DRL value‏‎ (2 revisions)
  256. Subcutaneous tissue‏‎ (2 revisions)
  257. Low dose rate‏‎ (2 revisions)
  258. Transfer compartment‏‎ (2 revisions)
  259. Mitigation‏‎ (2 revisions)
  260. Upper reference levels‏‎ (2 revisions)
  261. Neurovascular syndrome‏‎ (2 revisions)
  262. Epithelium‏‎ (2 revisions)
  263. Pelagic‏‎ (2 revisions)
  264. Practical radiological protection culture‏‎ (2 revisions)
  265. Acceptance test‏‎ (2 revisions)
  266. Gastrulation‏‎ (2 revisions)
  267. Radioactive source‏‎ (2 revisions)
  268. Habitual mouth breather‏‎ (2 revisions)
  269. Annihilation photons‏‎ (2 revisions)
  270. Hyperfractionation‏‎ (2 revisions)
  271. Bone marrow‏‎ (2 revisions)
  272. Risk coefficient‏‎ (2 revisions)
  273. Individual monitoring‏‎ (2 revisions)
  274. Containment‏‎ (2 revisions)
  275. Source term‏‎ (2 revisions)
  276. Latent time/period or latency interval‏‎ (2 revisions)
  277. Low level waste‏‎ (2 revisions)
  278. Dose-length product‏‎ (2 revisions)
  279. Equieffective dose‏‎ (2 revisions)
  280. Expanded and aligned radiation field‏‎ (2 revisions)
  281. Qualified expert‏‎ (2 revisions)
  282. Adventitious‏‎ (2 revisions)
  283. Radioactive substance‏‎ (2 revisions)
  284. Habitual nose breather‏‎ (2 revisions)
  285. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  286. Background dose (rate)‏‎ (2 revisions)
  287. Reference biokinetic model‏‎ (2 revisions)
  288. Relocation‏‎ (2 revisions)
  289. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  290. Intervention Level‏‎ (2 revisions)
  291. Substantial radiation dose level‏‎ (2 revisions)
  292. Detriment‏‎ (2 revisions)
  293. Dose-rate effect‏‎ (2 revisions)
  294. Transfer rate‏‎ (2 revisions)
  295. Multi-detector computed tomography‏‎ (2 revisions)
  296. Electron-capture decay‏‎ (2 revisions)
  297. Percutaneous coronary intervention‏‎ (2 revisions)
  298. Prevailing circumstances‏‎ (2 revisions)
  299. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  300. Radon Recommendations for Authorities‏‎ (2 revisions)
  301. Hypoplasia‏‎ (2 revisions)
  302. Backscatter detection system‏‎ (2 revisions)
  303. Reference individual‏‎ (2 revisions)
  304. Bradycardia‏‎ (2 revisions)
  305. Remedial action‏‎ (2 revisions)
  306. Risk of Exposure to Radon‏‎ (2 revisions)
  307. Coronary heart disease‏‎ (2 revisions)
  308. South Atlantic anomaly‏‎ (2 revisions)
  309. Interventional procedure‏‎ (2 revisions)
  310. Decay constant‏‎ (2 revisions)
  311. Lymphatic system‏‎ (2 revisions)
  312. Transforming growth factor‏‎ (2 revisions)
  313. Dose of record Hp (10)‏‎ (2 revisions)
  314. Electrophysiology‏‎ (2 revisions)
  315. Pericarditis‏‎ (2 revisions)
  316. Principle of application of dose limits‏‎ (2 revisions)
  317. Accreditation‏‎ (2 revisions)
  318. Genomic integrity‏‎ (2 revisions)
  319. Radioactivity‏‎ (2 revisions)
  320. Hazard‏‎ (2 revisions)
  321. Radon Recommendations for Workplaces‏‎ (2 revisions)
  322. Reference level‏‎ (2 revisions)
  323. Bragg peak‏‎ (2 revisions)
  324. Remediation‏‎ (2 revisions)
  325. Chronic exposure‏‎ (2 revisions)
  326. Routine monitoring‏‎ (2 revisions)
  327. ICRPædia Guide to Radon‏‎ (2 revisions)
  328. Colony‏‎ (2 revisions)
  329. Cosmic Radiation in Aviation‏‎ (2 revisions)
  330. Special (non-routine) monitoring‏‎ (2 revisions)
  331. Decommissioning‏‎ (2 revisions)
  332. Lifetime risk‏‎ (2 revisions)
  333. Macrophage colony stimulating factor‏‎ (2 revisions)
  334. Dose-threshold‏‎ (2 revisions)
  335. Multiplicative risk projection model‏‎ (2 revisions)
  336. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  337. Action Level‏‎ (2 revisions)
  338. Health Surveillance‏‎ (2 revisions)
  339. Basal cell‏‎ (2 revisions)
  340. Branching fraction‏‎ (2 revisions)
  341. Repopulation‏‎ (2 revisions)
  342. Class SR-0 gases‏‎ (2 revisions)
  343. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  344. Decontamination‏‎ (2 revisions)
  345. Diastasis‏‎ (2 revisions)
  346. Threshold dose for tissue reactions‏‎ (2 revisions)
  347. Magnetosphere‏‎ (2 revisions)
  348. Dose per unit intake coefficient‏‎ (2 revisions)
  349. Emergency‏‎ (2 revisions)
  350. Exposure, external or internal‏‎ (2 revisions)
  351. Graft vs host disease‏‎ (2 revisions)
  352. Air-kerma, incident‏‎ (2 revisions)
  353. Radiographer‏‎ (2 revisions)
  354. Heliosphere‏‎ (2 revisions)
  355. Representative organism (non-human biota)‏‎ (2 revisions)
  356. Class SR-1 gases‏‎ (2 revisions)
  357. Safety‏‎ (2 revisions)
  358. Committed effective dose‏‎ (2 revisions)
  359. Cost-benefit analysis‏‎ (2 revisions)
  360. Specific effective energy‏‎ (2 revisions)
  361. Decontamination factor‏‎ (2 revisions)
  362. Limitation of dose‏‎ (2 revisions)
  363. Transmission detection system‏‎ (2 revisions)
  364. Multistage tumorigenesis‏‎ (2 revisions)
  365. Dose rate‏‎ (2 revisions)
  366. Non-sphericity parameter‏‎ (2 revisions)
  367. Emergency exposure situation‏‎ (2 revisions)
  368. Erythropoietin‏‎ (2 revisions)
  369. Pharynx‏‎ (2 revisions)
  370. Exposure (in the context of inhalation)‏‎ (2 revisions)
  371. Fractionation and dose delivery patterns‏‎ (2 revisions)
  372. Broad beam therapy irradiation technique‏‎ (2 revisions)
  373. Representative person‏‎ (2 revisions)
  374. Class SR-2 gases‏‎ (2 revisions)
  375. Safety case‏‎ (2 revisions)
  376. Committed equivalent dose‏‎ (2 revisions)
  377. Slow repair‏‎ (2 revisions)
  378. Isotropic geometry‏‎ (2 revisions)
  379. Lineal energy‏‎ (2 revisions)
  380. Dichotomous‏‎ (2 revisions)
  381. Thyroid blocking‏‎ (2 revisions)
  382. Transparency‏‎ (2 revisions)
  383. Dose rate effectiveness factor‏‎ (2 revisions)
  384. Waste disposal‏‎ (2 revisions)
  385. Non-targeted effects‏‎ (2 revisions)
  386. Emergency plan‏‎ (2 revisions)
  387. Ethics‏‎ (2 revisions)
  388. ALARA‏‎ (2 revisions)
  389. Procedural values‏‎ (2 revisions)
  390. Hierarchical tissues‏‎ (2 revisions)
  391. Area monitoring‏‎ (2 revisions)
  392. Benthic‏‎ (2 revisions)
  393. Bronchial region‏‎ (2 revisions)
  394. Reproductive integrity‏‎ (2 revisions)
  395. Clearance‏‎ (2 revisions)
  396. Safety culture‏‎ (2 revisions)
  397. Solar cosmic radiation‏‎ (2 revisions)
  398. Inhalability‏‎ (2 revisions)
  399. Spontaneous fission‏‎ (2 revisions)
  400. Itinerant (radiation) worker‏‎ (2 revisions)
  401. Deontological Ethics‏‎ (2 revisions)
  402. Linear-non-threshold model‏‎ (2 revisions)
  403. Differentiation‏‎ (2 revisions)
  404. Trapped particles‏‎ (2 revisions)
  405. Orphan source‏‎ (2 revisions)
  406. Planned exposure situation‏‎ (2 revisions)
  407. Progenitor cell‏‎ (2 revisions)
  408. Activity‏‎ (2 revisions)
  409. Radiation belt‏‎ (2 revisions - redirect page)
  410. High level waste‏‎ (2 revisions)
  411. Reasonableness‏‎ (2 revisions)
  412. Residual dose‏‎ (2 revisions)
  413. Respiratory protection‏‎ (2 revisions)
  414. Clearance level‏‎ (2 revisions)
  415. Scintigraphy‏‎ (2 revisions)
  416. Solar cycle‏‎ (2 revisions)
  417. Inner bremsstrahlung‏‎ (2 revisions)
  418. Systemic model‏‎ (2 revisions)
  419. Linear-quadratic dose response model‏‎ (2 revisions)
  420. Time factor‏‎ (2 revisions)
  421. Dose constraint‏‎ (2 revisions)
  422. Myocardial perfusion‏‎ (2 revisions)
  423. Early normal tissue responses‏‎ (2 revisions)
  424. What is Radon?‏‎ (2 revisions)
  425. Platelet-derived growth factor‏‎ (2 revisions)
  426. Radiation modifier‏‎ (2 revisions)
  427. Radiological protection principles‏‎ (2 revisions)
  428. Beta-minus decay‏‎ (2 revisions)
  429. Retrievability‏‎ (2 revisions)
  430. Immune system‏‎ (2 revisions)
  431. Institutional control‏‎ (2 revisions)
  432. Cumulative dose‏‎ (2 revisions)
  433. Stakeholder‏‎ (2 revisions)
  434. Tachycardia‏‎ (2 revisions)
  435. Tissue equivalent material‏‎ (2 revisions)
  436. Dose conversion coefficient‏‎ (2 revisions)
  437. Myocardial stress test‏‎ (2 revisions)
  438. Edema‏‎ (2 revisions)
  439. Oversight‏‎ (2 revisions)
  440. Excess relative risk‏‎ (2 revisions)
  441. Exposure situation‏‎ (2 revisions)
  442. Projected dose‏‎ (2 revisions)
  443. Growth factor‏‎ (2 revisions)
  444. Alimentary tract transfer factor‏‎ (2 revisions)
  445. Radionuclides of natural origin‏‎ (2 revisions)
  446. Recovery (cellular or tissue)‏‎ (2 revisions)
  447. Beta-plus decay‏‎ (2 revisions)
  448. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  449. ICRP Publication 96‏‎ (1 revision)
  450. ICRP Publication 130‏‎ (1 revision)
  451. Secondary radiation‏‎ (1 revision)
  452. ICRP Publication 145‏‎ (1 revision)
  453. Intake‏‎ (1 revision)
  454. ICRP Publication 2‏‎ (1 revision)
  455. Standard-size adult‏‎ (1 revision)
  456. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  457. Derived consideration reference level‏‎ (1 revision)
  458. ICRP Publication 40‏‎ (1 revision)
  459. Tissue reaction‏‎ (1 revision)
  460. Measured quantity‏‎ (1 revision)
  461. ICRP Publication 55‏‎ (1 revision)
  462. Dose conversion convention‏‎ (1 revision)
  463. Tumour suppressor gene‏‎ (1 revision)
  464. National DRL‏‎ (1 revision)
  465. ICRP Publication 7‏‎ (1 revision)
  466. ICRP Publication 84‏‎ (1 revision)
  467. Oxygen enhancement ratio‏‎ (1 revision)
  468. Exclusion‏‎ (1 revision)
  469. Population risk‏‎ (1 revision)
  470. Acute exposure‏‎ (1 revision)
  471. Allometry‏‎ (1 revision)
  472. ICRP Publication 102‏‎ (1 revision)
  473. Registry‏‎ (1 revision)
  474. ICRP Publication 116‏‎ (1 revision)
  475. ICRP Publication 97‏‎ (1 revision)
  476. ICRP Publication 131‏‎ (1 revision)
  477. Secretory cells‏‎ (1 revision)
  478. ICRP Publication 146‏‎ (1 revision)
  479. Concentration ratio‏‎ (1 revision)
  480. Intensity-modulated radiotherapy‏‎ (1 revision)
  481. ICRP Publication 20‏‎ (1 revision)
  482. Stem cell‏‎ (1 revision)
  483. Kerma approximation‏‎ (1 revision)
  484. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  485. Derived investigation level‏‎ (1 revision)
  486. ICRP Publication 41‏‎ (1 revision)
  487. Directional dose equivalent‏‎ (1 revision)
  488. ICRP Publication 56‏‎ (1 revision)
  489. Dose conversion factor‏‎ (1 revision)
  490. National radon survey‏‎ (1 revision)
  491. ICRP Publication 70‏‎ (1 revision)
  492. Effect modifier‏‎ (1 revision)
  493. ICRP Publication 85‏‎ (1 revision)
  494. Endosteum‏‎ (1 revision)
  495. Potential alpha energy concentration‏‎ (1 revision)
  496. Redox‏‎ (1 revision)
  497. Biological half-life‏‎ (1 revision)
  498. ICRP Publication 117‏‎ (1 revision)
  499. ICRP Publication 98‏‎ (1 revision)
  500. ICRP Publication 132‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)